Gene expression profiling of ductal carcinomas in situ and invasive breast tumors

Anticancer Research

Volumn 23, Issue 3 A, 2003, Pages 2043-2051

  Seth, Arun ^a   Kitching, Richard ^a   Landberg, Goran ^c   Xu, Jing ^b   Zubovits, Judit ^b   Burger, Angelika M ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE

Author keywords

Breast cancer; Gene expression profiling; Genomics; Interferon genes

Indexed keywords

ACYLTRANSFERASE; ALDEHYDE DEHYDROGENASE; AQUAPORIN; CARBOXYPEPTIDASE H; COLLAGEN DERIVATIVE; COMPLEMENT; COMPLEMENTARY DNA; CYCLINE; DISINTEGRIN; EPITHELIAL MEMBRANE ANTIGEN; FIBRILLIN; GLOBIN; HYPOCALCIN; IMMUNOGLOBULIN LAMBDA CHAIN; KALLIKREIN; LACTOFERRIN; LAMININ; LUMICAN; MELANOMA ANTIGEN; MESSENGER RNA; PROPERDIN; RETINOIC ACID RECEPTOR; RIBONUCLEASE; RNA; SERINE; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN 1; SYNDECAN; UNINDEXED DRUG; ZINC FINGER PROTEIN;

BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST TUMOR; CANCER GRADING; CANCER GROWTH; CARCINOMA IN SITU; CONFERENCE PAPER; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; GENE ISOLATION; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARRIER PROTEINS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 0041805434     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Allred DC: Biologic and genetic features of in situ breast cancer. In: Ductal Carcinoma In Situ of the Breast, (Silverstein MJ, eds), Baltimore, Williams and Wilkins, 1997, p 37.
2. Ernster VL: Epidemiology and natural history of ductal carcinoma in situ. In: Ductal Carcinoma In Situ, (Silverstein MJ, eds), Baltimore, Williams and Wilkins, 1997, pp 23-33.
3. Ernster VL, Barclay J, Kerlikowske K, Grady D and Henderson C: Incidence of and treatment for ductal carcinoma In Situ of the breast. JAMA 275: 913-8, 1996.
4. Ernster VL and Barclay J: Increases in ductal carcinoma In Situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monogr 22: 151-6, 1997.
5. Ravdin PM: Biomarkers. In: Ductal Carcinoma In Situ, (Silverstein MJ, eds), Baltimore, Williams and Wilkins, 1997, pp 51-57.
6. Eriksson ET, Schimmelpenning H, Aspenblad U, Zetterberg A and Auer GU: Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease. Hum Pathol 25: 1228-33, 1994.
7. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-9, 1987.
8. Burger A, Li H, Zhang XK, Pienkowska M, Venanzoni M, Vournakis J, Papas T and Seth A: Breast cancer genome anatomy: correlation of morphological changes in breast carcinomas with expression of the novel gene product Di12. Oncogene 16: 327-33, 1998.
9. Xu J and Attisano L: Mutations in the, tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 97: 4820-5, 2000.
10. Landberg G, Ostlund H, Nielsen NH, Emdin S, Burger AM and Seth A: Down-regulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpresson, and increased proliferation in estrogen receptor-negative tumors. Oncogene 20: 3497-3505, 2001.
11. Burger AM, Zhang X, Li H, Ostrowski JL, Beatty B, Venanzoni M, Papas T and Seth A: Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene 16: 2459-67, 1998.
12. Kitching R, Li H, MJ W, Kanaganayakam S, Kahn H and Seth A: Characterization of a novel human breast cancer associated gene (BCA3) encoding an alternatively spliced proline rich protein. Biochimica et Biophysica Acta 1625: 116-121, 2003.
13. Mitsuyasu RT: Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma. Br J Haematol 79 Suppl 1: 69-73, 1991.
14. DeVita VTJ, Hellman S and Rosenberg SA: Cancer: Principles & Practice, 4th ed, Philadelphia, J. B. Lippincott Company, 1993
15. Hadden JW: The immunology and immunotherapy of breast cancer: an update. Int J Immunopharmacol 21: 79-101, 1999.
16. Hansen WJ, Cowan NJ and Welch WJ: Prefoldin-nascent chain complexes in the folding of cytoskeletal proteins. J Cell Biol 145: 265-77, 1999.
17. Vainberg IE, Lewis SA, Rommelaere H, Ampe C, Vandekerckhove J, Klein HL and Cowan NJ: Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. Cell 93: 863-73, 1998.
18. Iijima M, Kano Y, Nohno T and Namba M: Cloning of cDNA with possible transcription factor activity at the G1-S phase transition in human fibroblast cell lines. Acta Med Okayama 50: 73-7, 1996.
19. Beurton F, Gueret G, Horisberger M, Cheron G and Cresteil T: Transcriptional activation of CYP2C, MxA and Fas in sudden infant death syndrome. Int J Mol Med 3: 33-9, 1999.
20. Vaarala MH, Porvari K, Kyllonen A and Vihko P: Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression. Lab Invest 80: 1259-68, 2000.
21. Friedman RL, Manly SP, McMahon M, Kerr IM and Stark GR: Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38: 745-55, 1984.
22. Tahara H, Kamada K, Sato E, Tsuyama N, Kim JK, Hara E, Oda K and Ide T: Increase in expression levels of interferon-inducible genes in senescent human diploid fibroblasts and in SV40-transformed human fibroblasts with extended lifespan. Oncogene 11: 1125-32, 1995.
23. Tiwari RK, Wong GY, Mukhopadhyay B, Telang NT, Liu J, Hakes TB and Osborne MP: Interferon-alpha and gamma mediated gene responses in a human breast carcinoma cell line. Breast Cancer Res Treat 18: 33-41, 1991.
24. McMahon M, Stark GR and Kerr IM: Interferon-induced gene expression in wild-type and interferon-resistant human lymphoblastoid (Daudi) cells. J Virol 57:362-6, 1986.
25. Guille MJ, Laxton CD, Rutherford MN, Williams BR and Kerr IM: Functional differences in the promoters of the interferon-inducible (2′-5′)A oligoadenylate synthetase and 6-16 genes in interferon-resistant Daudi cells. Eur J Biochem 219: 547-53, 1994.
26. Gjermandsen IM, Justesen J and Martensen PM: The interferon-induced gene ISG12 is regulated by various cytokines as the gene 6-16 in human cell lines. Cytokine 12: 233-8, 2000.
27. Kocher O, Comella N, Gilchrist A, Pal R, Tognazzi K, Brown LF and Knoll JH: PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein. Lab Invest 79: 1161-70, 1999.
28. Kocher O, Comella N, Tognazzi K and Brown LF: Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains. Lab Invest 78: 117-25, 1998.
29. Ghosh MG, Thompson DA and Weigel RJ: PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 60: 6367-75, 2000.
30. Lawrance IC, Fiocchi C and Chakravarti S: Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 10: 445-56, 2001.
31. Autiero M, Cammarota G, Friedlein A, Zulauf M, Chiappetta G, Dragone V and Guardiola J: A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells. Eur J Immunol 25: 1461-4, 1995.
32. Jinquan T, Vorum H, Larsen CG, Madsen P, Rasmussen HH, Gesser B, Etzerodt M, Honore B, Celis JE and Thestrup-Pedersen K: Psoriasin: a novel chemotactic protein. J Invest Dermatol 107:5-10, 1996.
33. Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, Niu Y, Hiller-Hitchcock T, Hole K, Murphy LC and Watson PH: Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 155: 2057-66, 1999.
34. Enerback C, Porter DA, Seth P, Sgroi D, Gaudet J, Weremowicz S, Morton CC, Schnitt S, Pitts RL, Stampl J, Barnhart K and Polyak K: Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res 62: 43-7, 2002.
35. Myal Y, Robinson DB, Iwasiow B, Tsuyuki D, Wong P and Shiu RP: The prolactin-inducible protein (PIP/GCDFP-15) gene: cloning, structure and regulation. Mol Cell Endocrinol 80: 165-75, 1991.
36. Caputo E, Manco G, Mandrich L and Guardiola J: A novel aspartyl proteinase from apocrine epithelia and breast tumors. J Biol Chem 275: 7935-41, 2000.
37. Leygue E, Snell L, Dotzlaw H, Hole K, Hiller-Hitchcock T, Roughley PJ, Watson PH and Murphy LC: Expression of lumican in human breast carcinoma. Cancer Res 58: 1348-52, 1998.
38. Leygue E, Snell L, Dotzlaw H, Troup S, Hiller-Hitchcock T, Murphy LC, Roughley PJ and Watson PH: Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol 192: 313-20, 2000.
39. Collins C, Volik S, Kowbel D, Ginzinger D, Ylstra B, Cloutier T, Hawkins T, Predki P, Martin C, Wernick M, Kuo WL, Alberts A and Gray JW: Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res 11: 1034-42, 2001.